MYHEP ALL contains Sofosbuvir (NS5B polymerase inhibitor) and Velpatasvir (NS5A inhibitor), which together block the replication of the hepatitis C virus at multiple stages.
Recommended for:
- Treatment of all HCV genotypes (1–6)
- Patients with or without compensated cirrhosis
- Interferon-free therapy
- Patients who failed previous treatment
- 12-week short-course therapy
Array
(
[actionUrl] => [[+assetsUrl]]action.php
[form] => admin@sacred-leaves.com,idrees@sacred-leaves.com,info@sacred-leaves.com
[formSelector] => ajax_form
[frontend_css] => [[+assetsUrl]]css/default.css
[frontend_js] => [[+assetsUrl]]js/default.js
[objectName] => AjaxForm
[snippet] => FormIt
[hooks] => email
[emailTpl] => tpl.simple-email
[emailSubject] => Сообщение с сайта
[emailTo] => verfut@yandex.ru
[validate] => username:required, tel:required
[validationErrorMessage] => В форме содержатся ошибки!
[successMessage] => Сообщение успешно отправлено
)